HRP970325B1 - Controlled release formulation for poorly soluble basic drugs - Google Patents
Controlled release formulation for poorly soluble basic drugsInfo
- Publication number
- HRP970325B1 HRP970325B1 HRP970325A HRP970325B1 HR P970325 B1 HRP970325 B1 HR P970325B1 HR P970325 A HRP970325 A HR P970325A HR P970325 B1 HRP970325 B1 HR P970325B1
- Authority
- HR
- Croatia
- Prior art keywords
- controlled release
- release formulation
- poorly soluble
- soluble basic
- basic drugs
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HRP970325 HRP970325B1 (en) | 1997-06-13 | 1997-06-13 | Controlled release formulation for poorly soluble basic drugs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HRP970325 HRP970325B1 (en) | 1997-06-13 | 1997-06-13 | Controlled release formulation for poorly soluble basic drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP970325A2 HRP970325A2 (en) | 1999-04-30 |
HRP970325B1 true HRP970325B1 (en) | 2001-10-31 |
Family
ID=10946593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP970325 HRP970325B1 (en) | 1997-06-13 | 1997-06-13 | Controlled release formulation for poorly soluble basic drugs |
Country Status (1)
Country | Link |
---|---|
HR (1) | HRP970325B1 (en) |
-
1997
- 1997-06-13 HR HRP970325 patent/HRP970325B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HRP970325A2 (en) | 1999-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL121275A (en) | Controlled release formulation for poorly soluble basic drugs | |
EP1124543A4 (en) | Controlled release formulation for water soluble drugs | |
GB2341550B (en) | Gastroretentive controlled release microspheres for improved drug delivery | |
AU5914999A (en) | Controlled release drug delivery | |
IL130737A0 (en) | Emulsion vehicle for poorly soluble drugs | |
GB9826662D0 (en) | Controlled release formulation | |
ZA982872B (en) | Pharmaceutical formulation | |
AU7578598A (en) | Controlled release dosage forms containing water soluble drugs | |
HUP0104472A3 (en) | Sustained release matrix systems for highly soluble drugs | |
HRP20000213B1 (en) | Extended release formulation | |
HUP0003840A3 (en) | Controlled released medical formulation | |
NO996161L (en) | A controlled release formulation for heavily soluble basic drugs | |
HK1015677A1 (en) | Rapamycin formulations for oral administration | |
IL132986A0 (en) | Rapamycin formulation for oral administration | |
GB9709739D0 (en) | Pharmaceutical formulation | |
IL148543A0 (en) | Pharmaceutical carrier formulation | |
AU9587198A (en) | Immediate release drug delivery forms | |
ZA981775B (en) | Pharmaceutical formulations containing poorly soluble drug substances | |
GB9909154D0 (en) | Pharmaceutical formulation | |
HRP970325B1 (en) | Controlled release formulation for poorly soluble basic drugs | |
HUP0004132A3 (en) | Rapidly soluble drug composition | |
AU7799198A (en) | Method for preparing pharmaceutical formulation | |
GB9811622D0 (en) | Drug formulation | |
ZA9898B (en) | Emulsion vehicle for poorly soluble drugs | |
HU0400312D0 (en) | Extended release formulation containing venlaflaxine hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
PPPP | Transfer of rights |
Owner name: BGP PRODUCTS OPERATIONS GMBH, CH |
|
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20160523 Year of fee payment: 20 |
|
PB20 | Patent expired after termination of 20 years |
Effective date: 20170613 |